Sakar Healthcare Limited has informed the Exchange regarding Cessation of Mr Prashant C. Srivastav as Independent Director of the company w.e.f. September 23, 2025 upon completion of second term.
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sakar Healthcare Limited has informed the stock exchange that three Independent Directors will cease to hold office. Mr. Prashant C. Srivastav and Mr. Shailesh B. Patel stepped down on September 23, 2025 after completing their second term, coinciding with the conclusion of the 21st Annual General Meeting. A third Independent Director, Mr. Hemendrakumar C. Shah, will cease to be a director on September 27, 2025 upon completion of his tenure. The board has placed on record its appreciation for their contributions during their association with the company. The company has not announced any new appointments to replace them in this filing.
This is a routine end-of-tenure event and not a sudden resignation, so it should not materially affect the stock. However, investors should watch for announcements regarding the appointment of new Independent Directors, as the board will need to fill these three independent director positions to comply with SEBI listing requirements on board composition.